(Q33789117)

29 July 2017

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence (English)

1 reference

Adaptive radiation therapy

29 July 2017

0 references

1 reference

Karel Decaestecker

1

1 reference

29 July 2017

Gert De Meerleer

2

1 reference

29 July 2017

Bieke Lambert

3

1 reference

29 July 2017

Louke Delrue

4

1 reference

29 July 2017

Valérie Fonteyne

5

1 reference

29 July 2017

Tom Claeys

6

1 reference

29 July 2017

Filip De Vos

7

1 reference

29 July 2017

Wouter Huysse

8

1 reference

29 July 2017

Arne Hautekiet

9

1 reference

29 July 2017

Gaethan Maes

10

1 reference

29 July 2017

Piet Ost

11

1 reference

29 July 2017

12 June 2014

1 reference

29 July 2017

1 reference

29 July 2017

9

1 reference

29 July 2017

135

1 reference

https://scigraph.springernature.com/pub.10.1186/1748-717x-9-135

29 July 2017

0 references

cites work

The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Non-castrate metastatic prostate cancer: have the treatment options changed?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Stereotactic body radiotherapy for oligometastases.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

ESUR prostate MR guidelines 2012

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Randomized study evaluating testosterone recovery using short-versus long-acting luteinizing hormone releasing hormone agonists

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Stereotactic body radiation therapy: the report of AAPM Task Group 101.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Role of MRI in follow-up after focal therapy for prostate carcinoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

The natural history of noncastrate metastatic prostate cancer after radical prostatectomy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer.

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-135

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-135

Is there a favorable subset of patients with prostate cancer who develop oligometastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-135

Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-135

18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-135

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-135

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-135

Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-135

Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

11C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Oligometastases revisited

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4066290

Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24920079

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1748-717X-9-135

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference